The Veterans Spinal Trauma Access to New Devices (Veterans STAND) Act adds a new subsection to 38 U.S.C. §1706 that requires the Department of Veterans Affairs to offer an annual preventative health evaluation to any veteran with a spinal cord injury or disorder who elects to undergo it. The bill spells out the topics that evaluation must cover—risk of complications and comorbidities, chronic pain, diet/weight management, prosthetic equipment functioning and safety, and the suitability of assistive technologies including spinal cord neuromodulation—and authorizes delivery by direct care, referral, or VA telehealth.
Beyond evaluations, the Act creates a statutory definition of covered assistive technologies (explicitly naming powered exoskeletons, speech generators, non‑invasive transcutaneous spinal stimulation, and FDA‑approved implantable systems), requires VA consultation with clinical and technology experts and manufacturers when setting guidance, directs telehealth training and remote follow‑up “as clinically appropriate,” and mandates an initial report within one year and biennial reports thereafter with utilization and outcome metrics. These mechanics matter because they expand VA’s operational obligations without changing statutory entitlement language, set reporting and performance incentives, and embed a formal pathway for newer neuromodulation and exoskeleton technologies into VA practice.
At a Glance
What It Does
The bill requires the VA to offer an annual preventative health evaluation to veterans with a spinal cord injury or disorder, specifying five assessment areas including assistive‑technology suitability and prosthetic safety. It defines ‘assistive technology’ to include powered exoskeletons, speech generating devices, non‑invasive spinal neuromodulation, and FDA‑approved implantable stimulators, and authorizes telehealth delivery of training and monitoring.
Who It Affects
Directly affects veterans with spinal cord injuries or disorders, VA spinal cord program managers and specialists, VA telehealth operations, and manufacturers of assistive technologies (including exoskeleton and neuromodulation device makers). It will also touch VA contracting, prosthetics clinics, and Veterans Integrated Service Network (VISN) performance reviewers.
Why It Matters
The Act operationalizes annual, structured screening for risks and assistive‑tech suitability and creates a reporting regime that will track prescriptions and functional outcomes—potentially accelerating VA adoption of emerging devices while creating new clinical, procurement, and performance-management responsibilities for the Department.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill inserts a new subsection into VA law directing the Secretary to offer an annual preventative health evaluation to any veteran with a spinal cord injury or disorder who chooses it. The VA may provide the evaluation directly, by referral to other providers, or via its telehealth programs.
The evaluation is not just a general checkup: the statute lists discrete assessment areas the clinician must address, including risk factors for secondary complications, chronic pain and its management, nutrition and weight, prosthetic equipment needs and safety, and whether assistive technologies—explicitly including spinal cord neuromodulation approaches—are appropriate and usable at home.
For implementation the Secretary must consult a defined set of internal and external experts: VA spinal cord program managers, VA spinal cord specialist clinicians, clinicians and technologists with proven expertise in spinal neuromodulation therapies, and representatives of veterans’ organizations. The bill also requires the Secretary to consult manufacturers and other relevant entities about any guidance, rules, or regulations that would directly affect them.
The Act further requires that the VA, to the extent possible, provide annual notice to known veterans with spinal cord injuries or disorders about the availability and potential benefits of the evaluation.The statute authorizes, as clinically appropriate, that training, device programming, remote monitoring, and follow‑up for assistive technologies be delivered through telehealth. It also adds reporting obligations: the VA must submit an initial report one year after enactment and then every two years that enumerates how many veterans used, were assessed for, and were prescribed assistive technologies; it must, when available, categorize prescribed devices (including spinal cord neuromodulation) and summarize associated functional outcomes.
Finally, the VA must consider the provision of these evaluations when reviewing VISN performance metrics for years beginning a year after enactment.The Act concludes with a statutory definition of ‘assistive technology’ limited to powered medical or electronic devices used for spinal cord injury or disorder symptoms, listing powered exoskeletons, speech generating devices, non‑invasive transcutaneous spinal stimulation (sensory/afferent), and—where clinically appropriate—FDA‑approved implantable spinal cord stimulation systems.
The Five Things You Need to Know
The bill requires VA to offer (not automatically provide) an annual preventative health evaluation to any veteran with a spinal cord injury or disorder who elects it.
The evaluation must cover five named areas: risk of spinal‑related complications/comorbidities, chronic pain and its management, dietary/weight management, prosthetic equipment needs and safety, and assistive‑technology suitability including home use and training needs.
The Secretary must consult specified stakeholders when issuing guidance: VA spinal cord program managers, VA specialist clinicians, neuromodulation clinicians/technologists, veterans’ organization representatives, and—where guidance affects them—manufacturers and related entities.
VA must submit an initial report to Congress within one year and then every two years identifying counts of veterans who used, were assessed for, or were prescribed assistive technologies; for prescribed technologies the report must identify device categories and summarize functional outcomes if available.
The statute defines ‘assistive technology’ to include powered exoskeletons, speech generating devices, non‑invasive transcutaneous spinal stimulation, and, as clinically appropriate and consistent with VA prosthetics policy, FDA‑approved implantable spinal cord stimulation systems.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Mandatory offer of annual preventative evaluation
This provision directs VA to furnish—by direct care, referral, or VA telehealth—an annual preventative health evaluation to any veteran with a spinal cord injury or disorder who elects it. Practically, it creates a recurring outreach and clinical workflow obligation: VA must identify eligible veterans, offer the evaluation annually, and be prepared to deliver it through multiple care pathways.
Specified content of the evaluation
The statute lists five discrete assessment domains (complication/comorbidity risk, chronic pain, diet/weight, prosthetic equipment functioning and safety, and assistive‑technology suitability including home use and training). That level of specificity constrains clinical guidance and creates clear expectations for documentation and referrals following the evaluation—useful for standardizing care but requiring clinics to adopt new checklists and decision points.
Consultation requirements for guidance and outreach duties
Before adopting guidance, rules, or regulations implementing the subsection, VA must consult with internal spinal cord program managers and specialists, external neuromodulation experts, and veterans’ organization representatives; it must also consult manufacturers if guidance would directly affect them. The section also mandates annual informational outreach to veterans known to have spinal cord injuries or disorders. These requirements institutionalize stakeholder input but may lengthen rulemaking and raise potential conflicts when manufacturers are consulted on policies that affect procurement.
Telehealth for training, programming, and remote follow‑up
The Secretary may provide training, device programming, remote monitoring, and follow‑up for assistive technologies via telehealth where clinically appropriate. This permits decentralized management of complex devices (like neuromodulation systems) and should expand access for rural veterans, but it also requires VA to build or scale telehealth workflows, cybersecurity measures, and clinician training specific to device programming and troubleshooting.
Reporting to Congress on utilization and outcomes
VA must submit an initial report within one year and then biennially including counts of veterans who used, were assessed for, or were prescribed assistive technologies, plus device category identification and a summary of functional outcomes when available. Because outcome reporting is qualified by ‘if available,’ the provision pushes VA toward outcome tracking but stops short of mandating standardized functional outcome measures, potentially limiting comparability across VISNs and devices.
VISN performance consideration
The Secretary must consider provision of the mandated evaluations when reviewing Veterans Integrated Service Network performance metrics for relevant years. Inserting the evaluations into performance reviews creates an administrative lever to increase compliance, but it also ties local network performance assessments to what may be an under‑resourced new requirement.
Statutory definition of ‘assistive technology’
The subsection defines assistive technology narrowly as powered medical or electronic devices used for spinal cord injury/disorder symptoms and lists specific categories—powered exoskeletons, speech generating devices, non‑invasive transcutaneous spinal stimulation (sensory/afferent), and clinically appropriate FDA‑approved implantable stimulation systems. That definition focuses VA procurement and reporting but leaves other categories (home modifications, non‑powered aids) outside the statutory list unless covered by existing prosthetics policy.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans with spinal cord injuries or disorders — receive structured, annual assessment focused on prevention, prosthetic safety, and suitability for novel assistive technologies, and may gain faster access to telehealth‑enabled training and follow‑up.
- Rural and homebound veterans — benefit from the explicit authorization to receive training, device programming, and remote monitoring via VA telehealth, which reduces travel barriers to device management and follow‑up care.
- Manufacturers and developers of exoskeletons and neuromodulation technologies — gain a clearer pathway into VA care through defined device categories, mandated consultation before guidance affecting them, and regular VA reporting that could support evidence development and procurement decisions.
- VA spinal cord injury programs and specialists — obtain a statutory mandate and clearer expectations for standardized preventative evaluations, which can justify resource allocation and program development.
- Veterans’ advocacy and service organizations — receive formalized consultation roles and a mechanism (reporting and outreach) to ensure veterans are informed about evaluation opportunities.
Who Bears the Cost
- Department of Veterans Affairs — must absorb the operational costs of annual outreach, administration of evaluations, expanded telehealth services, clinician training, device programming capacity, and ongoing reporting without an appropriation in the text.
- VA clinicians and spinal cord clinics — face increased clinical workload, documentation, and potential training burdens to assess device suitability, manage neuromodulation programming, and provide remote follow‑up.
- VISNs and local networks — will have the evaluation provision considered in performance reviews, potentially requiring reallocation of personnel or funding to meet new expectations.
- Smaller assistive‑technology suppliers and vendors — may face new administrative burdens complying with VA consultations, device categorization, and outcome reporting requirements tied to VA procurement and clinical pathways.
- Congressional oversight and committees — will need to review biennial reports and may be asked to consider appropriations or policy changes if reporting shows increased demand or cost pressures.
Key Issues
The Core Tension
The central tension is between accelerating veteran access to promising but still‑evolving assistive technologies (and formalizing preventative, standardized evaluations) and the practical need to guard against premature, costly adoption without clear, consistent evidence or funding: the Act pushes VA to identify and connect veterans to devices while leaving coverage, procurement funding, and standardized outcome measurement to subsequent VA policy and resource decisions.
The Act creates operational and reporting requirements that expand VA’s responsibilities but does not itself change eligibility or entitlement rules for receiving assistive technologies. In practice, that means veterans may be identified as candidates for devices through the mandated evaluation without any statutory guarantee that VA will cover acquisition, ongoing programming, or maintenance beyond existing prosthetics policies.
Implementation will therefore hinge on VA’s internal policies, medical necessity criteria, and procurement practices.
The bill explicitly embraces emerging technologies—non‑invasive transcutaneous spinal stimulation and powered exoskeletons—but ties adoption to clinical appropriateness and available evidence. The reporting requirement asks for functional outcomes “if available,” which encourages outcome tracking but stops short of demanding standardized, validated measures that would allow apples‑to‑apples comparisons across devices and VISNs.
Requiring manufacturer consultation before issuing guidance raises useful practical input but also introduces potential conflicts of interest and could slow rulemaking. Operationalizing telehealth‑based programming and remote follow‑up for complex devices will require investment in clinician training, cybersecurity and data systems, and protocols for liability and device failure management—items the statute does not fund or detail.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.